3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Recurrence
1
Philadelphia Chromosome
1
Interventions
pirtobrutinib
1
nilotinib
1
idelalisib
1
bosutinib
1
Vincristine
1
Rituximab
1
Prednisone
1
Imatinib Mesylate
1
Doxorubicin
1
Cyclophosphamide
1
Brentuximab Vedotin
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Hematologic Diseases
×
asciminib
×
Clear all
No trials found.